Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPA-15406 foam in children with atopic dermatitis
NCT07184645Phase 3Not yet recruiting
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Sep 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of difamilast in atopic dermatitis (AD), sponsored by Otsuka Pharmaceutical Co., Ltd.. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
difamilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07184645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07184645.